Cargando…
Management of Pulmonary Arterial Hypertension
PURPOSE OF REVIEW: This review focuses on the therapeutic management and individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food and Drug Administration-approved PAH-specific therapies and various interventional and surgical options for PAH. RECENT FINDINGS: The para...
Autores principales: | Mayeux, Jennalyn D., Pan, Irene Z., Dechand, John, Jacobs, Joshua A., Jones, Tara L., McKellar, Stephen H., Beck, Emily, Hatton, Nathan D., Ryan, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671829/ https://www.ncbi.nlm.nih.gov/pubmed/33224405 http://dx.doi.org/10.1007/s12170-020-00663-3 |
Ejemplares similares
-
Management of Acute Pulmonary Embolism
por: Tice, Connor, et al.
Publicado: (2020) -
Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension
por: Pan, Irene Z., et al.
Publicado: (2020) -
Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease
por: Muir, A R, et al.
Publicado: (2009) -
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial
por: Jorstad, Harald T, et al.
Publicado: (2013) -
Effect of l-phenylalanine on PAL activity and production of naphthoquinone pigments in suspension cultures of Arnebia euchroma (Royle) Johnst
por: Sykłowska-Baranek, Katarzyna, et al.
Publicado: (2012)